Atlas Capital Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-465
| Closed | -$18K | – | 964 |
|
|
2025
Q1 | $18K | Buy |
+465
| New | +$18K | ﹤0.01% | 746 |
|
|
2024
Q4 | – | Sell |
-5,758
| Closed | -$235K | – | 954 |
|
|
2024
Q3 | $235K | Buy |
5,758
+608
| +12% | +$24.9K | 0.04% | 351 |
|
|
2024
Q2 | $198K | Sell |
5,150
-608
| -11% | -$23.4K | 0.03% | 382 |
|
|
2024
Q1 | $247K | Buy |
5,758
+68
| +1% | +$2.92K | 0.04% | 334 |
|
|
2023
Q4 | $211K | Buy |
5,690
+4,904
| +624% | +$182K | 0.03% | 362 |
|
|
2023
Q3 | $28.5K | Hold |
786
| – | – | ﹤0.01% | 604 |
|
|
2023
Q2 | $28K | Sell |
786
-493
| -39% | -$17.6K | ﹤0.01% | 641 |
|
|
2023
Q1 | $45.5K | Hold |
1,279
| – | – | 0.01% | 578 |
|
|
2022
Q4 | $44.9K | Hold |
1,279
| – | – | 0.01% | 555 |
|
|
2022
Q3 | $37.6K | Sell |
1,279
-10,822
| -89% | -$318K | 0.01% | 572 |
|
|
2022
Q2 | $658K | Sell |
12,101
-63
| -0.5% | -$3.43K | 0.11% | 153 |
|
|
2022
Q1 | $662K | Buy |
12,164
+126
| +1% | +$6.86K | 0.1% | 175 |
|
|
2021
Q4 | $664K | Buy |
12,038
+11,834
| +5,801% | +$652K | 0.1% | 176 |
|
|
2021
Q3 | $9.74K | Buy |
+204
| New | +$9.74K | ﹤0.01% | 727 |
|
|
2021
Q1 | – | Sell |
-1,373
| Closed | -$63.1K | – | 806 |
|
|
2020
Q4 | $63.1K | Buy |
+1,373
| New | +$63.1K | 0.01% | 449 |
|
|
2020
Q2 | – | Sell |
-138
| Closed | -$6.56K | – | 700 |
|
|
2020
Q1 | $6.56K | Buy |
+138
| New | +$6.56K | ﹤0.01% | 602 |
|
|
2019
Q3 | – | Sell |
-15,825
| Closed | -$792K | – | 661 |
|
|
2019
Q2 | $792K | Buy |
15,825
+11,629
| +277% | +$582K | 0.26% | 106 |
|
|
2019
Q1 | $219K | Hold |
4,196
| – | – | 0.08% | 251 |
|
|
2018
Q4 | $200K | Buy |
+4,196
| New | +$200K | 0.08% | 255 |
|